The robotic surgery landscape keeps expanding, and Edge is one of the newest platforms to arrive in Europe — with CE marking granted in October 2025. Its entry into the market confirms something many of us anticipated some time ago: soft-tissue surgical robots are going to be plenty. The real question for each of them today is not how good they are, but rather whether they are “good enough”.
From a design and functional perspective, Edge is a very clear derivative — one could say a close reinterpretation — of the fourth generation da Vinci system. That generation was introduced in 2014, more than a decade ago, and it defined the standard architecture that many current platforms still follow.
Edge has gone a step further in terms of portfolio breadth. Its robotic catalogue already includes not only a multi-port and single-port surgical system (currently offered as the MSP2000 “Super System”), but also a robotic bronchoscopy platform, clearly analogous to Intuitive´s Ion, aimed at navigation and intervention in the peripheral lung. This positions Edge not as a single product, but as a broader robotic ecosystem, something increasingly common among new entrants.
However, the timing matters. While Edge arrives to Europe with a mature and familiar architecture, we are already operating with the fifth generation of da Vinci (da Vinci 5). This latest generation does not simply refine mechanics (it introduces long-awaited haptic feedback), but is fundamentally designed for cloud connectivity, data integration, and AI-assisted surgical support. In other words, it represents a shift from pure telemanipulation toward augmented surgery (and some time, autonomous surgery).
So, what does Edge really offer us today?
On paper, it offers accessibility, competition (costs), and a proven robotic concept — one that many surgeons already understand intuitively because it mirrors a system we have been using for years. Also Multi-arm and Single-Port together if you are getting the MSP2000 and not the MP1000. Whether that is enough in a field that is now moving toward intelligent assistance, data-driven surgery, and connected platforms remains to be seen.
We are genuinely eager to evaluate Edge in real clinical settings, beyond specifications and demonstrations, to understand where it fits — and where it does not — in the current and future robotic surgery ecosystem.
For a more detailed overview of the Edge robotic platform, its configurations and potential applications, continue exploring our dedicated Edge section on headneckroboticsurgery.com.
J Granell. Feb 7, 2026.